ArticleACS omega2022

Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells.

Mohamed F Youssef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.